CONSORT and clinical trial reporting: room for improvement
Four-factor prothrombin complex concentrates for warfarin reversal: do real-world outcomes differ from controlled clinical trials?
Spur cell hemolytic anemia in liver failure
Evaluation of CONSORT compliance in TRANSFUSION
How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures?
Thromboembolic outcomes after use of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal in a real-world setting
Effect of blood transfusion on intestinal blood flow and oxygenation in extremely preterm infants during first week of life
Red blood cell transfusion is associated with further bleeding and fresh-frozen plasma with mortality in nonvariceal upper gastrointestinal bleeding
Hematopoietic peripheral circulating blood stem cells as an independent marker of good transfusion management in patients with β-thalassemia: results from a preliminary study
Transmission of human immunodeficiency virus Type-1 by fresh-frozen plasma treated with methylene blue and light
Application of mutant JAK2 V617F for in vitro generation of red blood cells
Shape matters: the effect of red blood cell shape on perfusion of an artificial microvascular network
Identified metabolic signature for assessing red blood cell unit quality is associated with endothelial damage markers and clinical outcomes
Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells
Further observations on the clinical significance and inheritance of the low-frequency platelet antigen HPA-28bw
Class I and II HLA antibodies in pediatric patients with thalassemia major
Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin
Engraftment for CD34 selected stem cell products is not compromised by cryopreservation
Human bone marrow processing using a new continuous-flow cell separation device
Erythrophagocytosis by plasmacytoid dendritic cells and monocytes is enhanced during inflammation
Postoperative anemia and early functional outcomes after fast-track hip arthroplasty: a prospective cohort study
Mathematical model and calculation to predict the effect of prophylactic plasma transfusion on change in international normalized ratio in critically ill patients with coagulopathy
Effect of intravenous iron on outcomes of acute kidney injury
Perioperative blood ordering optimization process using information from an anesthesia information management system
The c.64_80del SMIM1 allele is segregating in the Hutterite population
Compound heterozygosity of two novel RHAG alleles leads to a considerable disruption of the Rh complex
Cascade plasmapheresis as preconditioning regimen for ABO-incompatible renal transplantation: a single-center experience
Extracorporeal photopheresis in solid organ transplant–associated acute graft-versus-host disease
Rituximab-refractory thrombotic thrombocytopenic purpura responsive to intravenous but not subcutaneous bortezomib
Unexpected red blood cell antibody distributions in Chinese people by a systematic literature review
Metabolomics in transfusion medicine
Routine nucleic acid testing of blood donations fails to detect all human immunodeficiency virus–positive blood donors
Remembering James W. Mosley, MD (1929-2015), and his legacy in transfusion safety
Comment on Stotler BA, Schwartz J. How we use WinRho in patients with idiopathic thrombocytopenic purpura. Transfusion 2015:55:2547-50.
Mesenchymal stromal cells: are they ready for prime time?
Characterization of mesenchymal stem or stromal cells: tissue sources, heterogeneity, and function
Adult adherent cell therapy for ischemic stroke: clinical results and development experience using MultiStem
Mesenchymal stromal cells: potential roles in graft-versus-host disease prophylaxis and treatment
“Next-generation” mesenchymal stem or stromal cells for the in vivo delivery of bioactive factors: progressing toward the clinic
Challenges in the cGMP manufacturing of MSCs for multicenter academia trials
Challenges in translating mesenchymal stem cell therapies for trauma and critical care
Process automation in manufacturing of mesenchymal stromal cells
Redefining the role of blood establishments as raw material suppliers, manufacturers, and distributors for new cell therapies: the Blood Systems experience
Characterization of mesenchymal stromal cells: potency assay development